Inhibition of the mevalonate pathway: Benefits beyond cholesterol reduction?

Ziad A. Massy; William F. Keane; Bert L Kasiske

doi:10.1016/S0140-6736(96)90217-2

Inhibition of the mevalonate pathway: Benefits beyond cholesterol reduction?

Ziad A. Massy, William F. Keane, Bert L Kasiske

Medicine - Renal and Hypertension Division

Research output: Contribution to journal › Article › peer-review

161 Scopus citations

Original language	English (US)
Pages (from-to)	102-103
Number of pages	2
Journal	Lancet
Volume	347
Issue number	8994
DOIs	https://doi.org/10.1016/S0140-6736(96)90217-2
State	Published - Jan 13 1996

Publisher link

10.1016/S0140-6736(96)90217-2

Find It

Find It at U of M Libraries

Cite this

@article{93d95a3467e0433db89c0f8c19086825,

title = "Inhibition of the mevalonate pathway: Benefits beyond cholesterol reduction?",

author = "Massy, {Ziad A.} and Keane, {William F.} and Kasiske, {Bert L}",

year = "1996",

month = jan,

day = "13",

doi = "10.1016/S0140-6736(96)90217-2",

language = "English (US)",

volume = "347",

pages = "102--103",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8994",

}

TY - JOUR

T1 - Inhibition of the mevalonate pathway

T2 - Benefits beyond cholesterol reduction?

AU - Massy, Ziad A.

AU - Keane, William F.

AU - Kasiske, Bert L

PY - 1996/1/13

Y1 - 1996/1/13

UR - http://www.scopus.com/inward/record.url?scp=0030058148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030058148&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(96)90217-2

DO - 10.1016/S0140-6736(96)90217-2

M3 - Article

C2 - 8538301

AN - SCOPUS:0030058148

SN - 0140-6736

VL - 347

SP - 102

EP - 103

JO - The Lancet

JF - The Lancet

IS - 8994

ER -

Inhibition of the mevalonate pathway: Benefits beyond cholesterol reduction?

Publisher link

Find It

Other files and links

Cite this